SOLICITATION NOTICE
A -- Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
- Notice Date
- 9/25/2025 8:02:49 AM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) Washington DC 20005 USA
- ZIP Code
- 20005
- Solicitation Number
- ARPA-H-SOL-25-122
- Response Due
- 12/19/2025 8:59:00 PM
- Archive Date
- 01/03/2026
- Point of Contact
- THRIVE PROGRAM
- E-Mail Address
-
THRIVE@arpa-h.gov
(THRIVE@arpa-h.gov)
- Small Business Set-Aside
- NONE No Set aside used
- Description
- The Advanced Research Projects Agency for Health (ARPA-H) Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program envisions a future where patients can opt for one-time therapeutic interventions designed to slow, reverse, or cure disease, harnessing revolutionary technologies and a rapidly evolving understanding of the genetic underpinnings of the biological processes that lead to disease. Interested parties are invited to review the attached THRIVE Innovative Solutions Opening (ISO) ARPA-H -SOL-25-122. For detailed information regarding Proposers' Day review Special Notice (SN) ARPA-H-SN-25-131. Solution summaries are due October 31, 2025, 11:59 PM ET. For more information about THRIVE, please visit:https://arpa-h.gov/explore-funding/programs/thrive
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/c35d47c1cc4d40b0b496d2d62d894495/view)
- Place of Performance
- Address: Washington, DC 20005, USA
- Zip Code: 20005
- Country: USA
- Zip Code: 20005
- Record
- SN07604362-F 20250927/250925230046 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |